Search

Subject Periodicals

19021. 186 Vitamin and Mineral Supplementation During Gestation does not Influence Milk Yield or Composition During Early Lactation in Grazing or Parlor-Milked Beef Heifers. (12th April 2022)

Authors:
Baumgaertner, Friederike; Hurlbert, Jennifer L; Bochantin, Kerri A; Menezes, Ana Clara Baiao B; Sedivec, Kevin K; Kirsch, James D; Underdahl, Sarah R; Dahlen, Carl R
Journal:
Journal of animal science
Issue:
Volume 100(2022)Supplement 2
Page Start:
89
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19022. 186 Young Scholar Presentation: Immunometabolism during periods of negative nutrient balance or heat stress is altered by dietary methyl donor supply in dairy cows. (30th November 2020)

Authors:
Coleman, Danielle; Riboni, Mario Vailati; Pate, R; Miura, M; Luchini, N D; Trevisi, Erminio; Pan, X Y; Loor, Juan; Cardoso, Phil
Journal:
Journal of animal science
Issue:
Volume 98(2020)Supplement 3
Page Start:
13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19024. 1860 Last-line treatment of advanced breast cancer: Which clinical characteristics maypredict the outcome?. (September 2015)

Authors:
Cinausero, M.; Gerratana, L.; Iacono, D.; Bonotto, M.; Bozza, C.; Bolzonello, S.; Fanotto, V.; Poletto, E.; Fontanella, C.; Guardascione, M.; Minisini, A.M.; Russo, S.; Andreetta, C.; Moroso, S.; Sottile, R.; Mansutti, M.; Fasola, G.; Puglisi, F.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S285
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19025. 1861 Body mass index and prognosis in HER2-positive metastatic breast cancer patients. (September 2015)

Authors:
Poletto, E.; Minisini, A.M.; Ferreira, A.; Matteo, L.; Poggio, F.; Sottotetti, F.; Montemurro, F.; Pozzi, E.; Rossi, V.; Risi, E.; Dellepiane, C.; Sini, V.; Ziliani, S.; Minuti, G.; Mura, S.; Grasso, D.; Bertolini, I.; Del Mastro, L.; Puglisi, F.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S285
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19027. 1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab. (September 2015)

Authors:
Vaglica, M.; Lambertini, M.; Ferreira, A.; Poggio, F.; Puglisi, F.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Pozzi, E.; Risi, E.; Lai, A.; Zanardi, E.; Sini, V.; Ziliani, S.; Minuti, G.; Mura, S.; Grasso, D.; Ferrarini, I.; Pronzato, P.; Del Mastro, L.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19028. 1864 Chemotherapy versus endocrine therapy as first line treatment in patients with luminal-like metastatic breast cancer. Impact on survival. (September 2015)

Authors:
Bonotto, M.; Gerratana, L.; Arpino, G.; Di Maio, M.; De Angelis, C.; Iacono, D.; Cinausero, M.; Milano, M.; Gargiulo, P.; Fontanella, C.; Bozza, C.; Moroso, S.; Minisini, A.M.; Mansutti, M.; Fasola, G.; De Placido, S.; Puglisi, F.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19029. 1865 Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN). (September 2015)

Authors:
Patsouris, A.; Septans, A.L.; Paillard, M.J.; Pivot, X.; Soibinet, P.; Jovenin, N.; Robert, M.; Gourmelon, C.; Korembaum, C.; Petit, T.; Martin-babau, J.; Brunot, A.; Lefeuvre-plesse, C.; Adele, M.; Bourgeois, H.; Som, M.; Uwer, L.; Campone, M.; Campion, L.; Tredan, O.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S287
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19030. 1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC). (September 2015)

Authors:
Miles, D.; Cameron, D.; Bondarenko, I.; Lyudmila, M.; Alcedo, J.C.; Lopez, R.I.; Im, S.A.; Canon, J.L.; Shparyk, Y.; Yardley, D.; Masuda, N.; Ro, J.; Hubeaux, S.; Quah, C.; Bais, C.; O'Shaughnessy, J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S287
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗